Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001628280-20-016822)

Filing Details

Accession Number:: 0001628280-20-016822
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-25 16:02:46
Reporting Period:: 2020-11-23

Accepted Time:: 2020-11-25 16:02:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1213037	Cardiff Oncology Inc.	CRDF	Biological Products, (No Disgnostic Substances) (2836)	272004382

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1815809	Vicki Kelemen	C/O Cardiff Oncology, Inc. 11055 Flintkote Ave San Diego CA 92121	Exec. Vp And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-23	35,321	$2.48	40,375	No	4	M	Direct
Common Stock	Disposition	2020-11-23	35,321	$18.60	5,054	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2020-11-23	35,321	$2.48	35,321	$2.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,641		2029-06-20	No	4	M	Direct

Footnotes

The common stock was sold by the reporting person in a series of open market transactions on the transaction date at a weighted average sale price of $18.6014. The range of prices was $18.40 to $19.25. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares sold at each price.
35,321 options vested on 6/20/2020.